nach oben

Diabetologia

Erschienen in:

05.04.2016 | Mini-review

Hepatic glucose and lipid metabolism

verfasst von: John G. Jones

Erschienen in: Diabetologia | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

The liver has a central role in the regulation of systemic glucose and lipid fluxes during feeding and fasting and also relies on these substrates for its own energy needs. These parallel requirements are met by coordinated control of carbohydrate and lipid fluxes into and out of the Krebs cycle, which is highly tuned to nutrient availability and heavily regulated by insulin and glucagon. During progression of type 2 diabetes, hepatic carbohydrate and lipid biosynthesis fluxes become elevated, thus contributing to hyperglycaemia and hypertriacylglycerolaemia. Over this interval there are also significant fluctuations in hepatic energy state. To date, it is not known to what extent abnormal glucose and lipid fluxes are causally linked to altered energy states. Recent evidence that the glucose-lowering effects of metformin appear to be mediated by attenuation of hepatic energy generation places an additional spotlight on the interdependence of hepatic biosynthetic and oxidative fluxes. The transition from fasting to feeding results in a significant re-direction of hepatic glucose and lipid fluxes and may also incur a temporary hepatic energy deficit. At present, it is not known to what extent these variables are additionally modified by type 2 diabetes and/or non-alcoholic fatty liver disease. Thus, there is a compelling need to measure fluxes through oxidative, gluconeogenic and lipogenic pathways and determine their relationship with hepatic energy state in both fasting and fed conditions. New magnetic resonance-based technologies allow these variables to be non-invasively studied in animal models and humans. This review summarises a presentation given at the symposium entitled ‘The liver in focus’ at the 2015 annual meeting of the EASD. It is accompanied by two other reviews on topics from this symposium (by Kenneth Cusi, DOI: 10.1007/s00125-016-3952-1, and by Hannele Yki-Järvinen, DOI: 10.1007/s00125-016-3944-1) and a commentary by the Session Chair, Michael Roden (DOI: 10.1007/s00125-016-3911-x).

Koliaki C, Roden M (2013) Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol Cell Endocrinol 379:35–42CrossRefPubMed

Magnusson I, Schumann WC, Bartsch GE et al (1991) Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem 266:6975–6984PubMed

Diraison F, Large V, Brunengraber H, Beylot M (1998) Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM. Diabetologia 41:212–220CrossRefPubMed

Large V, Brunengraber H, Odeon M, Beylot M (1997) Use of labeling pattern of liver glutamate to calculate rates of citric acid cycle and gluconeogenesis. Am J Physiol 272:E51–E58PubMed

Sunny NE, Parks EJ, Browning JD, Burgess SC (2011) Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 14:804–810CrossRefPubMedPubMedCentral

Jin ES, Burgess SC, Merritt ME, Sherry AD, Malloy CR (2005) Differing mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs Zucker diabetic fatty rats by NMR analysis of plasma glucose. Am J Physiol Endocrinol Metab 288:E654–E662CrossRefPubMed

Burgess SC, Jeffrey FMH, Storey C et al (2005) Effect of murine strain on metabolic pathways of glucose production after brief or prolonged fasting. Am J Physiol Endocrinol Metab 289:E53–E61CrossRefPubMed

Jones JG, Solomon MA, Cole SM, Sherry AD, Malloy CR (2001) An integrated ²H and ¹³C NMR study of gluconeogenesis and TCA cycle flux in humans. Am J Physiol Endocrinol Metab 281:E848–E851PubMed

Jones JG, Solomon MA, Sherry AD, Jeffrey FMH, Malloy CR (1998) ¹³C NMR measurements of human gluconeogenic fluxes after ingestion of [U-¹³C]propionate, phenylacetate, and acetaminophen. Am J Physiol Endocrinol Metab 275:E843–E852

10.

Satapati S, Sunny NE, Kucejova B et al (2012) Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J Lipid Res 53:1080–1092CrossRefPubMedPubMedCentral

11.

Madiraju AK, Erion DM, Rahimi Y et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510:542–546CrossRefPubMedPubMedCentral

12.

Bridges HR, Jones AJY, Pollak MN, Hirst J (2014) Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J 462:475–487CrossRefPubMedPubMedCentral

13.

Tao H, Zhang Y, Zeng X, Shulman GI, Jin S (2014) Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. Nat Med 20:1263–1269CrossRefPubMedPubMedCentral

14.

Perry RJ, Zhang D, Zhang X-M, Boyer JL, Shulman GI (2015) Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347:1253–1256CrossRefPubMedPubMedCentral

15.

Landau BR, Schumann WC, Chandramouli V, Magnusson I, Kumaran K, Wahren J (1993) ¹⁴C-labeled propionate metabolism in vivo and estimates of hepatic gluconeogenesis relative to Krebs cycle flux. Am J Physiol 265:E636–E647PubMed

16.

Esenmo E, Chandramouli V, Schumann WC, Kumaran K, Wahren J, Landau BR (1992) Use of ¹⁴CO₂ in estimating rates of hepatic gluconeogenesis. Am J Physiol 263:E36–E41PubMed

17.

Schumann WC, Magnusson I, Chandramouli V, Kumaran K, Wahren J, Landau BR (1991) Metabolism of [2-¹⁴C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. J Biol Chem 266:6985–6990PubMed

18.

Iozzo P, Bucci M, Roivainen A et al (2010) Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology 139:846–856CrossRefPubMed

19.

Vogt JA, Yarmush DM, Yu YM et al (1997) TCA cycle flux estimates from NMR- and GC-MS-determined ¹³C glutamate isotopomers in liver. Am J Phys 272:C2049–C2062

20.

Jucker BM, Lee JY, Shulman RG (1998) In vivo ¹³C NMR measurements of hepatocellular tricarboxylic acid cycle flux. J Biol Chem 273:12187–12194CrossRefPubMed

21.

Befroy DE, Perry RJ, Jain N et al (2014) Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic ¹³C magnetic resonance spectroscopy. Nat Med 20:98–102CrossRefPubMedPubMedCentral

22.

Diraison F, Large V, Maugeais C, Krempf M, Beylot M (1999) Noninvasive tracing of human liver metabolism: comparison of phenylacetate and apoB-100 to sample glutamine. Am J Physiol Endocrinol Metab 277:E529–E536

23.

Yang DW, Previs SF, Fernandez CA et al (1996) Noninvasive probing of citric acid cycle intermediates in primate liver with phenylacetylglutamine. Am J Physiol Endocrinol Metab 270:E882–E889

24.

Weis BC, Margolis D, Burgess SC et al (2004) Glucose production pathways by ²H and ¹³C NMR in patients with HIV-associated lipoatrophy. Magn Reson Med 51:649–654CrossRefPubMed

25.

Sunny NE, Kalavalapalli S, Bril F et al (2015) Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. Am J Physiol Endocrinol Metab 309:E311–E319CrossRefPubMed

26.

Szendroedi J, Chmelik M, Schmid AI et al (2009) Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 50:1079–1086CrossRefPubMed

27.

Randle PJ (1998) Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14:263–283CrossRefPubMed

28.

Soares AF, Viega FJ, Carvalho RA, Jones JG (2009) Quantifying hepatic glycogen synthesis by direct and indirect pathways in rats under normal ad libitum feeding conditions. Magn Reson Med 61:1–5

29.

Soares AF, Carvalho RA, Veiga FJ et al (2012) Restoration of direct pathway glycogen synthesis flux in the STZ-diabetes rat model by insulin administration. Am J Physiol Endocrinol Metab 303:E875–E885CrossRefPubMed

30.

Delgado TC, Barosa C, Nunes PM, Cerdan S, Geraldes CFGC, Jones JG (2012) Resolving the sources of plasma glucose excursions following a glucose tolerance test in the rat with deuterated water and [U-¹³C]glucose. PLoS ONE 7, e34042CrossRefPubMedPubMedCentral

31.

Delgado TC, Martins FO, Carvalho F et al (2013) ²H enrichment distribution of hepatic glycogen from ²H₂O reveals the contribution of dietary fructose to glycogen synthesis. Am J Physiol Endocrinol Metab 304:E384–E391CrossRefPubMed

32.

Lee JJ, Lambert JE, Hovhannisyan Y et al (2015) Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. Am J Clin Nutr 101:34–43CrossRefPubMedPubMedCentral

33.

Diraison F, Pachiaudi C, Beylot M (1997) Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic mass spectrometric techniques. J Mass Spectrom 32:81–86CrossRefPubMed

34.

Diraison F, Pachiaudi C, Beylot M (1996) In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated. Metab: Clin Exp 45:817–821CrossRef

35.

Parks EJ, Hellerstein MK (2006) Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques. J Lipid Res 47:1651–1660CrossRefPubMed

36.

Duarte JAG, Carvalho F, Pearson M et al (2014) A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice. J Lipid Res 55:2541–2553CrossRefPubMedPubMedCentral

37.

Martins F, Delgado TC, Viegas J et al (2015) Mechanisms by which the thiazolidinedione troglitazone protects against sucrose-induced hepatic fat accumulation and hyperinsulinemia. Br J Pharmacol 173:267–278CrossRef

38.

Delgado TC, Pinheiro D, Caldeira M et al (2009) Sources of hepatic triglyceride accumulation during high-fat feeding in the healthy rat. NMR Biomed 22:310–317CrossRefPubMed

39.

Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig 115:1343–1351CrossRefPubMedPubMedCentral

40.

Diraison F, Moulin P, Beylot M (2003) Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 29:478–485CrossRefPubMed

41.

Parks EJ, Skokan LE, Timlin MT, Dingfelder CS (2008) Dietary sugars stimulate fatty acid synthesis in adults. J Nutr 138:1039–1046PubMedPubMedCentral

42.

Faeh D, Minehira K, Schwarz JM, Periasami R, Seongsu P, Tappy L (2005) Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 54:1907–1913CrossRefPubMed

43.

Schwarz J-M, Noworolski SM, Wen MJ et al (2015) Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J Clin Endocrinol Metab 100:2434–2442CrossRefPubMed

44.

Alves TC, Befroy DE, Kibbey RG et al (2011) Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance. Hepatology 53:1175–1181CrossRefPubMedPubMedCentral

45.

Knowles SE, Jarrett IG, Filsell OH, Ballard FJ (1974) Production and utilization of acetate in mammals. Biochem J 142:401–411CrossRefPubMedPubMedCentral

46.

Sone H, Shimano H, Sakakura Y et al (2002) Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status. Am J Physiol Endocrinol Metab 282:E222–E230CrossRefPubMed

47.

Vos MB (2014) Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field. Curr Opin Lipidol 25:61–66CrossRefPubMedPubMedCentral

48.

De Vadder F, Kovatcheva-Datchary P, Goncalves D et al (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156:84–96CrossRefPubMed

Titel: Hepatic glucose and lipid metabolism
verfasst von: John G. Jones
Publikationsdatum: 05.04.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Diabetologia / Ausgabe 6/2016
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-016-3940-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2016

Diagnosis of non-alcoholic fatty liver disease (NAFLD)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects

Egg consumption and risk of type 2 diabetes: a prospective study and dose–response meta-analysis

A short leucocyte telomere length is associated with development of insulin resistance

Erratum to: Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial